Cargando…
RNA and nanocarriers: next generation drug and delivery platform take center stage
The unprecedented rapid deployment of mRNA vaccines against COVID-19 can be traced back to the early studies of RNA nanocarriers, including the study by Zimmermann et al. which showcased the effectiveness of RNA nanocarriers in vivo. This study, among others, ultimately resulted in Onpattro, the fir...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9811353/ https://www.ncbi.nlm.nih.gov/pubmed/36609034 http://dx.doi.org/10.1016/j.tibtech.2022.12.019 |
| _version_ | 1784863515307147264 |
|---|---|
| author | Rouge, Jessica |
| author_facet | Rouge, Jessica |
| author_sort | Rouge, Jessica |
| collection | PubMed |
| description | The unprecedented rapid deployment of mRNA vaccines against COVID-19 can be traced back to the early studies of RNA nanocarriers, including the study by Zimmermann et al. which showcased the effectiveness of RNA nanocarriers in vivo. This study, among others, ultimately resulted in Onpattro, the first FDA-approved RNA formulation. |
| format | Online Article Text |
| id | pubmed-9811353 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-98113532023-01-04 RNA and nanocarriers: next generation drug and delivery platform take center stage Rouge, Jessica Trends Biotechnol Spotlight The unprecedented rapid deployment of mRNA vaccines against COVID-19 can be traced back to the early studies of RNA nanocarriers, including the study by Zimmermann et al. which showcased the effectiveness of RNA nanocarriers in vivo. This study, among others, ultimately resulted in Onpattro, the first FDA-approved RNA formulation. Elsevier Ltd. 2023-03 2023-01-04 /pmc/articles/PMC9811353/ /pubmed/36609034 http://dx.doi.org/10.1016/j.tibtech.2022.12.019 Text en © 2022 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Spotlight Rouge, Jessica RNA and nanocarriers: next generation drug and delivery platform take center stage |
| title | RNA and nanocarriers: next generation drug and delivery platform take center stage |
| title_full | RNA and nanocarriers: next generation drug and delivery platform take center stage |
| title_fullStr | RNA and nanocarriers: next generation drug and delivery platform take center stage |
| title_full_unstemmed | RNA and nanocarriers: next generation drug and delivery platform take center stage |
| title_short | RNA and nanocarriers: next generation drug and delivery platform take center stage |
| title_sort | rna and nanocarriers: next generation drug and delivery platform take center stage |
| topic | Spotlight |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9811353/ https://www.ncbi.nlm.nih.gov/pubmed/36609034 http://dx.doi.org/10.1016/j.tibtech.2022.12.019 |
| work_keys_str_mv | AT rougejessica rnaandnanocarriersnextgenerationdruganddeliveryplatformtakecenterstage |